Marinomed Biotech AG Market Capitalization: Historic Market Cap and Yearly Evolution

                        
Market Cap
Marinomed Biotech AG Market Capitalization:
                            €71.98 Billion
                            
                            EUR as of Jan. 1, 2023
                            
                                    US$76.72 Billion
                                
                        business
                        
                            Marinomed Biotech AG Company Profile
                        
                                    Marinomed Biotech AG Main Stock Listing
                                
                                show_chart
                                FSX: MBG

Market Capitalization History of Marinomed Biotech AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology

Company	Market Cap (USD)
Novo Nordisk	$304.61 B
CSL Limited	$93.24 B
Regeneron Pharmaceuticals, Inc.	$79.53 B
Vertex Pharmaceuticals Incorporated	$74.13 B
Moderna, Inc.	$68.42 B

Sector: Healthcare

Company	Market Cap (USD)
UnitedHealth Group	$495.37 B
Johnson & Johnson	$461.85 B
Lilly	$347.61 B
Novo Nordisk	$304.61 B
Pfizer	$287.63 B

Yearly evolution of Marinomed Biotech AG market cap

Date	Market Cap	YoY Change
Jan. 1, 2023	€71.98 B	-6.33%
Jan. 1, 2022	€76.84 B	21.50%
Jan. 1, 2021	€63.24 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Marinomed Biotech AG Categories

Healthcare Biotechnology

Stocks & Indices

Marinomed Biotech AG has the following listings and related stock indices.

Stock: FSX: MBG

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.